Literature DB >> 16374183

Effectiveness of prolonged glucocorticoid treatment in acute respiratory distress syndrome: the right drug, the right way?

G Umberto Meduri, George P Chrousos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16374183     DOI: 10.1097/01.ccm.0000196088.75067.4c

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  5 in total

Review 1.  Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis.

Authors:  John Victor Peter; Preeta John; Petra L Graham; John L Moran; Ige Abraham George; Andrew Bersten
Journal:  BMJ       Date:  2008-04-23

Review 2.  Virus-mediated modulation of the host endocrine signaling systems: clinical implications.

Authors:  Tomoshige Kino; George P Chrousos
Journal:  Trends Endocrinol Metab       Date:  2007-04-02       Impact factor: 12.015

3.  Corticosteroid Pulses for Hospitalized Patients with COVID-19: Effects on Mortality.

Authors:  David Andaluz-Ojeda; Roberto Gonzalez-Fuentes; Ivan Cusacovich; Álvaro Aparisi; Miguel Marcos; Cristina Ybarra-Falcón; Carolina Iglesias-Echevarria; Maria Lopez-Veloso; Julio Barraza-Vengoechea; Carlos Dueñas; Santiago Antonio Juarros Martínez; Beatriz Rodríguez-Alonso; José-Ángel Martín-Oterino; Miguel Montero-Baladia; Leticia Moralejo
Journal:  Mediators Inflamm       Date:  2021-03-12       Impact factor: 4.711

4.  Immunomodulatory therapy for the management of critically ill patients with COVID-19: A narrative review.

Authors:  David Andaluz-Ojeda; Pablo Vidal-Cortes; Álvaro Aparisi Sanz; Borja Suberviola; Lorena Del Río Carbajo; Leonor Nogales Martín; Estefanía Prol Silva; Jorge Nieto Del Olmo; José Barberán; Ivan Cusacovich
Journal:  World J Crit Care Med       Date:  2022-07-09

Review 5.  Sepsis: from bench to bedside.

Authors:  Eliézer Silva; Rogério Da Hora Passos; Maurício Beller Ferri; Luiz Francisco Poli de Figueiredo
Journal:  Clinics (Sao Paulo)       Date:  2008-02       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.